FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310786394> ?p ?o ?g. }

• W4310786394 endingPage "1050" @default.
• W4310786394 startingPage "1038" @default.
• W4310786394 abstract "Renal interstitial fibrosis is the common pathological process of various chronic kidney diseases to end-stage renal disease. Inhibition of fibroblast activation attenuates renal interstitial fibrosis. Our previous studies show that poricoic acid A (PAA) isolated from Poria cocos is a potent anti-fibrotic agent. In the present study we investigated the effects of PAA on renal fibroblast activation and interstitial fibrosis and the underlying mechanisms. Renal interstitial fibrosis was induced in rats or mice by unilateral ureteral obstruction (UUO). UUO rats were administered PAA (10 mg·kg-1·d-1, i.g.) for 1 or 2 weeks. An in vitro model of renal fibrosis was established in normal renal kidney fibroblasts (NRK-49F cells) treated with TGF-β1. We showed that PAA treatment rescued Sirt3 expression, and significantly attenuated renal fibroblast activation and interstitial fibrosis in both the in vivo and in vitro models. In TGF-β1-treated NRK-49F cells, we demonstrated that Sirt3 deacetylated β-catenin (a key transcription factor of fibroblast activation) and then accelerated its ubiquitin-dependent degradation, thus suppressing the protein expression and promoter activity of pro-fibrotic downstream target genes (twist, snail1, MMP-7 and PAI-1) to alleviate fibroblast activation; the lysine-49 (K49) of β-catenin was responsible for Sirt3-mediated β-catenin deacetylation. In molecular docking analysis, we found the potential interaction of Sirt3 and PAA. In both in vivo and in vitro models, pharmacological activation of Sirt3 by PAA significantly suppressed renal fibroblast activation via facilitating β-catenin K49 deacetylation. In UUO mice and NRK-49F cells, Sirt3 overexpression enhanced the anti-fibrotic effect of PAA, whereas Sirt3 knockdown weakened the effect. Taken together, PAA attenuates renal fibroblast activation and interstitial fibrosis by upregulating Sirt3 and inducing β-catenin K49 deacetylation, highlighting Sirt3 functions as a promising therapeutic target of renal fibroblast activation and interstitial fibrosis." @default.
• W4310786394 created "2022-12-17" @default.
• W4310786394 creator A5029300665 @default.
• W4310786394 creator A5037383338 @default.
• W4310786394 creator A5046662102 @default.
• W4310786394 creator A5056796466 @default.
• W4310786394 creator A5073070877 @default.
• W4310786394 creator A5078143614 @default.
• W4310786394 creator A5082240165 @default.
• W4310786394 creator A5083569864 @default.
• W4310786394 creator A5084485099 @default.
• W4310786394 creator A5088303852 @default.
• W4310786394 date "2022-12-05" @default.
• W4310786394 modified "2023-10-04" @default.
• W4310786394 title "Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation" @default.
• W4310786394 cites W2279912430 @default.
• W4310786394 cites W2543570310 @default.
• W4310786394 cites W2602710562 @default.
• W4310786394 cites W2755073985 @default.
• W4310786394 cites W2792388750 @default.
• W4310786394 cites W2800110090 @default.
• W4310786394 cites W2802168264 @default.
• W4310786394 cites W2807047540 @default.
• W4310786394 cites W2889018234 @default.
• W4310786394 cites W2889380083 @default.
• W4310786394 cites W2892543962 @default.
• W4310786394 cites W2914934977 @default.
• W4310786394 cites W2931210246 @default.
• W4310786394 cites W2934666577 @default.
• W4310786394 cites W2938240493 @default.
• W4310786394 cites W2961936258 @default.
• W4310786394 cites W2968023637 @default.
• W4310786394 cites W2980020667 @default.
• W4310786394 cites W2995256698 @default.
• W4310786394 cites W2999358087 @default.
• W4310786394 cites W3000568230 @default.
• W4310786394 cites W3005957464 @default.
• W4310786394 cites W3010286796 @default.
• W4310786394 cites W3021498845 @default.
• W4310786394 cites W3025671577 @default.
• W4310786394 cites W3033947697 @default.
• W4310786394 cites W3047879827 @default.
• W4310786394 cites W3087730663 @default.
• W4310786394 cites W3090036544 @default.
• W4310786394 cites W3090217815 @default.
• W4310786394 cites W3109793392 @default.
• W4310786394 cites W3112418112 @default.
• W4310786394 cites W3118483304 @default.
• W4310786394 cites W3123414479 @default.
• W4310786394 cites W3152694397 @default.
• W4310786394 cites W3173233941 @default.
• W4310786394 cites W3202341724 @default.
• W4310786394 cites W4210599841 @default.
• W4310786394 cites W4211136945 @default.
• W4310786394 cites W4221013115 @default.
• W4310786394 cites W4229508150 @default.
• W4310786394 cites W4236357753 @default.
• W4310786394 doi "https://doi.org/10.1038/s41401-022-01026-x" @default.
• W4310786394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36470978" @default.
• W4310786394 hasPublicationYear "2022" @default.
• W4310786394 type Work @default.
• W4310786394 citedByCount "1" @default.
• W4310786394 countsByYear W43107863942023 @default.
• W4310786394 crossrefType "journal-article" @default.
• W4310786394 hasAuthorship W4310786394A5029300665 @default.
• W4310786394 hasAuthorship W4310786394A5037383338 @default.
• W4310786394 hasAuthorship W4310786394A5046662102 @default.
• W4310786394 hasAuthorship W4310786394A5056796466 @default.
• W4310786394 hasAuthorship W4310786394A5073070877 @default.
• W4310786394 hasAuthorship W4310786394A5078143614 @default.
• W4310786394 hasAuthorship W4310786394A5082240165 @default.
• W4310786394 hasAuthorship W4310786394A5083569864 @default.
• W4310786394 hasAuthorship W4310786394A5084485099 @default.
• W4310786394 hasAuthorship W4310786394A5088303852 @default.
• W4310786394 hasBestOaLocation W43107863941 @default.
• W4310786394 hasConcept C104317684 @default.
• W4310786394 hasConcept C119157956 @default.
• W4310786394 hasConcept C126322002 @default.
• W4310786394 hasConcept C134018914 @default.
• W4310786394 hasConcept C185592680 @default.
• W4310786394 hasConcept C202751555 @default.
• W4310786394 hasConcept C2780091579 @default.
• W4310786394 hasConcept C2780381497 @default.
• W4310786394 hasConcept C2780559512 @default.
• W4310786394 hasConcept C502942594 @default.
• W4310786394 hasConcept C55493867 @default.
• W4310786394 hasConcept C71924100 @default.
• W4310786394 hasConceptScore W4310786394C104317684 @default.
• W4310786394 hasConceptScore W4310786394C119157956 @default.
• W4310786394 hasConceptScore W4310786394C126322002 @default.
• W4310786394 hasConceptScore W4310786394C134018914 @default.
• W4310786394 hasConceptScore W4310786394C185592680 @default.
• W4310786394 hasConceptScore W4310786394C202751555 @default.
• W4310786394 hasConceptScore W4310786394C2780091579 @default.
• W4310786394 hasConceptScore W4310786394C2780381497 @default.
• W4310786394 hasConceptScore W4310786394C2780559512 @default.
• W4310786394 hasConceptScore W4310786394C502942594 @default.
• W4310786394 hasConceptScore W4310786394C55493867 @default.

• next